U2 has released “Street of Dreams,” the first single from an upcoming studio album, marking the band’s first in nine years. Produced by Jacknife Lee, the track features Bono, The Edge, Adam Clayton, and Larry Mullen Jr. The band’s full album is expected to arrive later this year, coinciding with their 50th anniversary.
How Was the “Street of Dreams” Music Video Filmed?
Production for the “Street of Dreams” music video took place in Mexico City this past May. The shoot occurred near Plaza Santo Domingo. The production faced environmental challenges, including rain and thunder, which caused a generator to crash during filming. To continue the shoot, a local family allowed the band members to film from their balcony.
The band’s 50-year milestone traces back to September. That was when Larry Mullen Jr. posted a handwritten notice on the school noticeboard at Dublin’s Mount Temple Comprehensive, calling for musicians to form a band.
What Is the Context Behind the Upcoming Album?
This release serves as the first single from the band’s yet-to-be announced studio album. While the band has not yet announced the title of the upcoming record, they have confirmed it will be released later this year.

Were There Other Notable Appearances in Mexico?
During their time in Mexico City, the band members attended the 2026 Street Child World Cup Finals Tournament. The event was held at the Parque Ecológico Lago de Texcoco.
Frequently Asked Questions
When will the new U2 album be released?
The band has confirmed the album is due for release later this year, though a specific date has not yet been announced.
Who produced the single “Street of Dreams”?
The track was produced by Jacknife Lee.
How long has U2 been together?
The band will celebrate 50 years since their formation this September, dating back to Larry Mullen Jr.’s original notice at Mount Temple Comprehensive.
Keep an eye on the band’s official website for breaking news on the album title and upcoming tour announcements as the 50th-anniversary celebrations approach.
What are your thoughts on the new sound of “Street of Dreams”? Share your comments below or subscribe to our music newsletter for more updates on upcoming rock releases.
Worth a look
- Thomas Giertsen Sells Rental Apartment for 12 Million
- Film Industry Rallies Behind NAZA Directors Amid Condemnation
- Breakthrough Salk Study Uncovers Mechanism Behind Immunotherapy Resistance: Interferons, Mitochondrial Dysfunction, and PGE2″ Interferons, mitochondrial dysfunction and PGE2: Salk study reveals mechanism behind immunotherapy resistance. Boost its search engine visibility with relevant keywords for maximum impact. Immunotherapy resistance remains one of the biggest hurdles in cancer treatment. According to a recent study published in the journal Nature Communications, scientists at the Salk Institute have made a groundbreaking discovery that sheds light on the underlying mechanisms behind this resistance. The study reveals that interferons, a type of protein that plays a crucial role in the immune system, can contribute to mitochondrial dysfunction in cancer cells. This dysfunction can lead to the production of prostaglandin E2 (PGE2), a molecule that promotes tumor growth and resistance to immunotherapy. In their study, the researchers found that PGE2 production was a key factor in the development of immunotherapy resistance in cancer cells. The team used a combination of experimental and computational models to investigate the relationship between interferons, mitochondrial dysfunction, and PGE2 production. The findings of the study suggest that targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance. The researchers propose that blocking PGE2 receptors or inhibiting its production could help restore the function of mitochondria in cancer cells, making them more susceptible to immunotherapy. The study’s authors hope that their findings will pave the way for the development of new therapies that can overcome immunotherapy resistance and improve treatment outcomes for cancer patients. Key Takeaways: – Interferons contribute to mitochondrial dysfunction in cancer cells – Mitochondrial dysfunction leads to PGE2 production, promoting tumor growth and resistance to immunotherapy – Targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance – Restoring mitochondrial function in cancer cells could make them more susceptible to immunotherapy Keywords: immunotherapy resistance, interferons, mitochondrial dysfunction, PGE2, Salk Institute, cancer treatment, breakthrough study, Nature Communications. (archyworldys.com)